(Total Views: 461)
Posted On: 01/29/2021 12:28:59 PM
Post# of 145247
![](/m/assets/46931549/no_avatar_available_thumb.jpg)
More evidence our cancel trials will have success . Check out NK news on their IL-15 antagonist combo study for NSCLC. . Nantkwest is a stock I follow for a few years . LL is a multi inflammatory antagonistic drug that hits so many markers . I’m super hopeful . Please c-suite don’t screw it up I do believe they have improved since my time here , about a year . Does anyone else follow NK . The maker of so called natural killer cells . Maybe LL should go by Natural inflammation killer .
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)